BioCentury
ARTICLE | Clinical News

Crestor rosuvastatin regulatory update

November 11, 2002 8:00 AM UTC

The Netherlands granted marketing approval for Crestor rosuvastatin 10-40 mg from AZN to manage primary hypercholesterolemia and mixed dyslipidemia. The Netherlands Medicines Evaluation Board (MEB) wi...